# Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)

> **NCT06709339** · PHASE4 · RECRUITING · sponsor: **Association for Innovation and Biomedical Research on Light and Image** · enrollment: 120 (estimated)

## Conditions studied

- Polypoidal Choroidal Vasculopathy

## Interventions

- **DRUG:** Faricimab Injection [Vabysmo]

## Key facts

- **NCT ID:** NCT06709339
- **Lead sponsor:** Association for Innovation and Biomedical Research on Light and Image
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-06
- **Primary completion:** 2028-08
- **Final completion:** 2028-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06709339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06709339, "Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06709339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*